October 25-26, 2018 Infinity Hotel & Conference Resort, Munich, Germany
|
|
|
- Roland Gallagher
- 5 years ago
- Views:
Transcription
1 Programme 4 th CVOT Summit in cooperation with D&CVD EASD Study Group October 25-26, 2018 Infinity Hotel & Conference Resort, Munich, Germany Thursday, October 25, 2018 Room Ammersee I 18:00 18:30 Welcome, Introduction & Activities of the Study Group Schnell O (Munich, Germany), Ceriello A (Milan, Italy) 18:30 19:30 Keynote Lecture Chair: Ceriello A (Milan, Italy), Schnell O (Munich, Germany) 18:30 19:20 The Future of Diabetes Treatment in Europe: Decision-making and Patient Preferences Muehlbacher A (Neubrandenburg, Germany) 19:20 19:30 Discussion 19:45 Welcome reception
2 08:30 09:30 CVOTs 2018: Clinical Updates Chair: Itzhak B (Haifa, Israel), Valensi P (Bondy, France) 08:30 08:45 DPP-4 inhibitors Standl E (Munich, Germany) 08:45 09:00 SGLT-2 inhibitors Lalic N (Belgrade, Serbia) 09:00 09:15 GLP-1 receptor agonists Itzhak B (Haifa, Israel) 09:15 09:30 Discussion 09:30 10:30 Key therapeutic approaches (1) Chair: Standl E (Munich, Germany) 09:30 09:50 09:50 10:10 10:10 10:20 Cardiovascular effects of GLP-1 receptor agonists Cosentino F (Stockholm, Sweden) Supported by Novo Nordisk Treatment of Diabetes with SGLT-2 inhibitors: Potentials for optimization of heart failure outcomes Groop PH (Helsinki, Finland) Supported by Boehringer Ingelheim Oral Presentation: Linagliptin, cardiovascular safety and kidney outcomes in Typ-2- Diabetes: CARMELINA Trial Marx N (Aachen, Germany) 10:20 10:35 Discussion
3 10:35 11:00 Coffee Break 11:00 12:30 10 years after the FDA Guidance: Continue or change? Chair: Rydèn L (Stockholm, Sweden), Groop PH (Helsinki, Finland) 11:00 11:30 Unexpected knowledge gained Continue CVOTs Standl E (Munich, Germany) 11:30 12:00 Need for a change: Refocus and modify endpoints Home P (Newcastle, UK) 12:00 12:30 Panel Discussion 12:30 13:30 Lunch Break 13:30 14:30 Key therapeutic approaches (2) Chair: Catrinoiu D (Constanta, Romania) 13:30 14:00 Heart failure in Diabetes: Treatment Strategies with Valsartan / Sacubitril Marx N (Aachen, Germany) Supported by Novartis 14:00 14:30 CVOTs with PCSK9 inhibitors: Key learnings Mueller-Wieland D (Aachen, Germany)
4 14:30 15:00 Coffee Break 15:00 17:00 Adjunct Therapy in Type 1 Diabetes Chair: Schnell O (Munich, Germany) 15:00 15:10 Oral Presentation: Nationwide study of T1D vs. T2D: Characteristics and CV event rates Bodegard J (Oslo, Norway) 15:10 15:35 Type 1 Diabetes and CVD Rydèn L (Stockholm, Sweden) 15:35 16:00 Non-insulin Therapies in Type 1 Diabetes Battellino T (Ljubljana, Slovenia) 16:00 16:30 Panel Discussion 1 16:30 17:00 Industry s Perspective Bodegard J Carr R Muehlbacher A Pavo I Tadayon S and others
5 17:00 17:40 Oral Presentations Chair: Lalic N (Belgrade, Serbia), Battelino T (Ljubljana, Slovenia) 17:00 17:10 The relationship of insulin resistance and endothelial dysfunction with pro-inflammatory cytokines, adiponectin in patients with NAFLD Pivtorak, K (Vinnitsya, Ukraine) 17:10 17:20 Novel approaches to evaluate an early identification of diabetes La Sala L (Milan, Italy) 17:20 17:30 Type 2 diabetes increases the need for pacemaker and implantable cardioverter defibrillator treatment - A Swedish registry report Rautio E (Stockholm, Sweden) 17:30 17:40 Cardiac rehabilitation improves long-term survival of diabetic patients after coronary artery bypass graft surgery: a multicenter study with 13-y follow-up Dankner R (Ramat Gan, Israel)
6 17: Poster Presentations Poster Session 1: Treatment with GLP-1 receptor agonists, SGLT-2 inhibitors and other approaches Chair: Lalic N (Belgrade, Serbia) Poster Session 2: Diabetes and the Heart (1) Chair: Standl E (Munich, Germany) Poster Session 3: Diabetes and the Heart (2) Chair: Catrinoiu D (Constanta, Romania) Poster Session 4: Micro- and macrovascular complications beyond the heart Chair: Itzhak B (Haifa, Israel) Poster Session 5: Metabolic disturbances revisited Chair: Valensi P (Bondy, France) 18:20 18:30 Abstract Awards
5 th Annual Meeting Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group November 15-17, 2012 Paris, France
5 th Annual Meeting Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group November 15-17, 2012 Paris, France Thursday, November 15, 2012 18:00 19:30 DPP- 4 and cardiovascular disease Chairs: Ceriello
Monday 4 Dec Tuesday 5 Dec Wednesday 6 Dec Thursday 7 Dec Friday 8 Dec. Scientific Sessions. coffee break. Scientific Sessions
CONGRESS-AT-A-GLANCE Monday 4 Dec Tuesday 5 Dec Wednesday 6 Dec Thursday 7 Dec Friday 8 Dec 08.00 09.00 09.30 coffee break coffee break coffee break 10.00 Satellite Symposia 11.30 11.45 12.30 12.45 13.15
Thursday, June 30, 2016
Thursday, June 30, 2016 11:15-12:00 FID Board Meeting (Kursraum 4, U1) 12:00-13:00 Lunch-Symposium (sponsored by Boehringer Ingelheim; Auditorium Rossi) 13:45-14:10 Welcome address (Auditorium Rossi) R.
Visegrád, Hungary, February 22-25, 2018
EUROPEAN SOCIETY OF ENDOCRINOLOGY 22 nd Postgraduate Course in Clinical Endocrinology Visegrád, Hungary, February 22-25, 2018 Postgraduate Course Steering Committee Camilla Schalin-Jäntti, ESE Education
THURSDAY, 30 JUNE, 2016 FRIDAY, 1 JULY 2016
THURSDAY, 30 JUNE, 2016 18:00 18:30 OPENING CEREMONY Opening Lecture: TBA 18:30 19:30 Chairs: Maciej Banach (); Nathan D. Wong (Irvine, USA) 19:30 Get Together Reception FRIDAY, 1 JULY 2016 08:30 - Plenary
Cronfa - Swansea University Open Access Repository
Cronfa - Swansea University Open Access Repository This is an author produced version of a paper published in: The Lancet Diabetes & Endocrinology Cronfa URL for this paper: http://cronfa.swan.ac.uk/record/cronfa33201
Berzelius symposium no 96
Berzelius symposium no 96 23 25 MAY 2018 IN MALMÖ, SWEDEN Diabetes and the cardiovascular risk challenge mechanisms, epidemiology and treatment aspects Organising Committee: Peter M Nilsson, Professor,
eamda 39 th Annual General Meeting September 17-20, 2009, Beograd, SERBIA Under the auspices of the President of Serbia Boris Tadić
Under the auspices of the President of Serbia Boris Tadić Thursday, September 17 th, 2009 Arrival of Delegates / Transport from airport 16.00 17.00 Registration 17.30 19.00 Executive Committee Meeting
Engagement in language assessment / Regions of Europe
Summary table: Engagement in language / Regions of This table lists the statistically significant differences in the engagement in activities by the respondents from different s of : If the word or appears
PRELIMINARY PROGRAM. 14:10-15:00 Session I: My Personal Experience CT/MR Chair: Herbert Frank Tulln, Austria Udo Hoffmann Boston, USA
PRELIMINARY PROGRAM Thursday 5 October 2017 14:00 Welcome 14:10-15:00 Session I: My Personal Experience CT/MR Chair: 14:10 14:35 Tips and Tricks CMR Holger Thiele Leipzig, Germany 14:35 15:00 Tips and
Sponsorship and Exhibition Prospectus
30 November - 1 December 2016 Berlin Germany Sponsorship and Exhibition Prospectus Bio events Sharing Biomed knowledge Dear Colleagues The International Congress on Clinical Trials in Diabetes (WCTD2016),
Terapia con agonisti GLP1 e outcome cardiovascolare. Edoardo Mannucci
Terapia con agonisti GLP e outcome cardiovascolare Edoardo Mannucci Conflitti di interessi Negli ultimi due anni, E. Mannucci ha ricevuto compensi per relazioni e/o consulenze da: Abbott, AstraZeneca,
Nordic-Baltic Region University Research Course Gdańsk, Poland, September 19-21, 2019
Nordic-Baltic Region University Research Course Gdańsk, Poland, September 19-21, 2019 HYPERTENSION AND CARDIOVASCULAR DISEASE: Focus on Brain, Cognition, Stroke and Sympathetic Nervous System Activity
LATE BREAKING STUDIES IN DM AND CAD. Will this change the guidelines?
LATE BREAKING STUDIES IN DM AND CAD Will this change the guidelines? Objectives 1. Discuss current guidelines for prevention of CHD in diabetes. 2. Discuss the FDA Guidance for Industry regarding evaluating
8 th Congress of ECCO
European Crohn s and Colitis Organisation Vienna Austria 8 th Congress of ECCO Austria Center Vienna February 14-16, 2013 The major educational event in the field of Inflammatory Bowel Diseases in Europe
NCT Number: NCT
Efficacy and safety of insulin glargine 300 U/mL vs insulin degludec 100 U/mL in insulin-naïve adults with type 2 diabetes mellitus: Design and baseline characteristics of the BRIGHT study Alice Cheng
DIABETES AND MACROVASCULAR DISEASE
Second International Course on DIABETES AND MACROVASCULAR DISEASE Lugano (CH), March 27-29, 2003 Scientific Programme Thursday, March 27, 2003 15.45 16.00 Opening Remarks Session 1: DIABETES MELLITUS A
PRELIMINARY PROGRAMME
PRELIMINARY PROGRAMME 26 May 2017 ITALIAN LANGUAGE SYMPOSIUM PHARMACOLOGY IN INTERVENTIONAL CARDIOLOGY DAPT AFTER PCI 10.00 CONTROVERSY 1 - P2Y12 INHIBITION AFTER PCI IN STABLE PATIENTS Clopidogrel remains
Reducing the risk of CVD
1 The risk of developing cardiovascular disease (CVD) can be reduced in several ways. Lowering blood cholesterol levels and lowering blood pressure are two ways of reducing CVD. (a) (i) Complete the diagram
PROVISIONAL SCIENTIFIC PROGRAMME AND TIMETABLE
PROVISIONAL SCIENTIFIC PROGRAMME AND TIMETABLE Thursday 17 th October, 2013 09.00- : Executive meetings (only for the Executive and the International Advisory Boards of EURIPA and the Executive of EGPRN),
Can We Reduce Heart Failure by Treating Diabetes? CVOT Data on SGLT2 Inhibitors and GLP-1Receptor Agonists
Can We Reduce Heart Failure by Treating Diabetes? CVOT Data on SGLT2 Inhibitors and GLP-1Receptor Agonists Robert R. Henry, MD Professor of Medicine University of California, San Diego Relevant Conflict
Alcohol-related harm in Europe and the WHO policy response
Alcohol-related harm in Europe and the WHO policy response Lars Moller Programme Manager World Health Organization Regional Office for Europe Date of presentation NCD global monitoring framework: alcohol-related
WCPT COUNTRY PROFILE December 2017 SERBIA
WCPT COUNTRY PROFILE December 2017 SERBIA SERBIA NUMBERS WCPT Members Practising physical therapists 622 Total number of physical therapist members in your member organisation 3,323 Total number of practising
WCPT COUNTRY PROFILE December 2017 SWEDEN
WCPT COUNTRY PROFILE December 2017 SWEDEN SWEDEN NUMBERS WCPT Members Practising physical therapists 11,043 Total number of physical therapist members in your member organisation 17,906 Total number of
International. CytoSorb. Users Meeting. October 2 nd 2015 Pullman Hotel Schweizer Hof Berlin, Germany
2 nd International CytoSorb Users Meeting October 2 nd 2015 Pullman Hotel Schweizer Hof Berlin, Germany 2nd International CytoSorb Users Meeting Dear CytoSorb user, Just before the start of the 28th Annual
WCPT COUNTRY PROFILE December 2017 HUNGARY
WCPT COUNTRY PROFILE December 2017 HUNGARY HUNGARY NUMBERS WCPT Members Practising physical therapists 727 Total number of physical therapist members in your member organisation 4,000 Total number of practising
Where we stand in EFORT
Where we stand in EFORT Engaging with the new EU regulatory landscape for medical devices. Challenges & opportunities Brussel, Belgium April 6, 2018 Per Kjaersgaard-Andersen Associate Professor Section
Update on Diabetes Cardiovascular Outcome Trials
Update on Diabetes Cardiovascular Outcome Trials Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of Miami Miller School of Medicine
Preliminary PROGRAM. Thursday October 5, :00 Welcome Herbert Frank Tulln, AT. Session I: 14:10 15:00 MY PERSONAL EXPERIENCE CT/CMR
Preliminary PROGRAM Thursday October 5, 2017 14:00 Welcome Session I: 14:10 15:00 MY PERSONAL EXPERIENCE CT/CMR 14:10-14:35 Tips and Tricks CMR Holger Thiele Lübeck, DE 14:35-15:00 Tips and Tricks CT Matthias
La lezione dei trials di safety cardiovascolare. Edoardo Mannucci
La lezione dei trials di safety cardiovascolare Edoardo Mannucci Conflitti di interessi Negli ultimi due anni, E. Mannucci ha ricevuto compensi per relazioni e/o consulenze da: Abbott, AstraZeneca, Boehringer
8 th EuroCMR Meeting - Florence 2010 Start: Thursday, End: Saturday (+ CMR exam)
8 th EuroCMR Meeting - Florence 2010 Start: Thursday, 15.00 End: Saturday. 16.30 (+ CMR exam) Thursday; May 27 th, 2010 15.00-19.00 Satellite Symposium on Thalassemia 15.00-18.50 Session I Basic Course
EUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV. GUY DE BACKER Ghent University,Belgium
EUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV GUY DE BACKER Ghent University,Belgium ESC Congress 2012, aug.25-29th, Munich, Germany ESC Congress 2012, aug.25-29th, Munich,
PROGRAM. asian interchange on diabetes July in Bangkok, Thailand. Venue Centara Grand at Central World
PROGRAM asian interchange on diabetes 30 31 July in Bangkok, Thailand Venue Centara Grand at Central World BANGKOK 2016 JULY 30 & 31 ACROSS T2D Your gateway to the international expert forum for Type 2
Du gusts is megl che one. Edoardo Mannucci
Du gusts is megl che one Edoardo Mannucci Conflitti di interessi Negli ultimi due anni, E. Mannucci ha ricevuto compensi per relazioni e/o consulenze da: Abbott, AstraZeneca, Boehringer Ingelheim, Eli
PRELIMINARY PROGRAMME
www.sepseast2018.com PRELIMINARY PROGRAMME NOVEMBER 15-17, 2018 Danubius Health Spa Resort Helia Budapest, Hungary PROGRAM 15 NOVEMBER 2018, THURSDAY 08:20-08:30 WELCOME! Zsolt Molnar, Hungary 08:30-09:45
MONSUE. A European Multicentre Study on Suicidal Behaviour and Suicide Prevention. EU-Grant 2003/ MONSUE
MONSUE A European Multicentre Study on Suicidal Behaviour and Suicide Prevention EU-Grant 2003/791077-MONSUE Background In many European countries, suicidal behaviour constitutes a major public and mental
Program Schedule Cardiology Update in Sedona: The Heart of the Matter
Thursday, August 3, 2017 Program Schedule Cardiology Update in Sedona: The Heart of the Matter Noon Registration and Exhibits 1:50 p.m. Welcome Announcements SESSION 1 MODERATORS: Luis R. Scott, M.D and
Current and future market dynamics overview
OVERVIEW Catalyst Summary EXECUTIVE SUMMARY Strategic scoping and focus Datamonitor key findings Related reports MARKET DEFINITION Published diabetes reports Market definition for antidiabetic drugs Forecast
Management of Type 2 Diabetes Cardiovascular Outcomes Trials Tom Blevins MD Texas Diabetes and Endocrinology Austin, Texas
Management of Type 2 Diabetes Cardiovascular Outcomes Trials 2018 Tom Blevins MD Texas Diabetes and Endocrinology Austin, Texas Speaker Disclosure Dr. Blevins has disclosed that he has received grant support
Version 1.11 of 20/07/2018
Version 1.11 of 20/07/2018 NICE JANUARY 17-19, 2019 6 th International Workshop on Lung Health New approaches to respiratory diseases PRESIDENTS: F. BLASI, G.W. CANONICA CHAIRMEN: S. CENTANNI, J.C. VIRCHOW,
4:30 p.m. Jack Vogel Memorial Lecture Evolution and Revolution in the Treatment of Valvular Heart Disease Dr. Mack
AGENDA Friday, January 12 4:30 p.m. Registration at Westin Snowmass Conference Center 6:30 p.m. Saturday, January 13 3:30 p.m. Registration and Refreshment Break SESSION I Moderator: 4:00 p.m. Welcome
The Cardiac Patient from Birth to Adulthood February 2019 in Stockholm Sweden
The Cardiac Patient from Birth to Adulthood 21 22 February 2019 in Stockholm Sweden The symposium is arranged by the Journal of Internal Medicine Acta Paediatrica Swedish Society of Medicine Berzelius
Voting feature in App. Breaks Optional Event Educational Session Meet the expert INGID Working Party
TIMETABLE Plenary Workshop Special Breaks Optional Event Educational Meet the expert INGID Working Party Wednesday 24 October 2018 I 08:30-09:00 Educational Lecture - Lymphoproliferation in PIDs 09:00-09:30
The cancer burden in the European Union and the European Region: the current situation and a way forward
The cancer burden in the European Union and the European Region: the current situation and a way forward Presented by Zsuzsanna Jakab WHO Regional Director for Europe Informal Meeting of Health Ministers
KDIGO Controversies Conference on Management of Patients with Diabetes and Chronic Kidney Disease
KDIGO Controversies Conference on Management of Patients with Diabetes and Chronic Kidney Disease February 5-8, 2015 Vancouver, Canada Kidney Disease: Improving Global Outcomes (KDIGO) is an international
Organized by. Scientific comittee
July 11 & 12, 2019 Institut Pasteur Organized by Arun Sanyal Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA Lawrence Serfaty Hôpital Hautepierre Hôpitaux Universitaires de
32 nd European NEUROLOGY CONGRESS
conferenceseries.com 32 nd European NEUROLOGY CONGRESS July 22-24, 2019 London, UK SCIENTIFIC PROGRAM conferenceseries.com 32 ND EUROPEAN NEUROLOGY CONGRESS Dear colleague, We are glad to announce the
CLINICAL ONCOLOGY 3 RD BALKAN AND EASTERN EUROPEAN MASTERCLASS IN May 2013 Dubrovnik, Croatia. Chair: R. Popescu, CH/RO Co-chair: S.
MASTERCLASS 3 RD BALKAN AND EASTERN EUROPEAN MASTERCLASS IN CLINICAL ONCOLOGY 8-12 May 2013 Dubrovnik, Croatia Chair: Co-chair: S. Beslija, BA Aims and objectives This clinically oriented residential educational
Current perspectives on cardiovascular outcome trials in diabetes
DOI 10.1186/s12933-016-0456-8 Cardiovascular Diabetology REVIEW Open Access Current perspectives on cardiovascular outcome trials in diabetes Oliver Schnell 1*, Lars Rydén 2, Eberhard Standl 1, Antonio
Core Curriculum for the Cardiovascular Clinician
September 14 17, 2016 Heart House Washington, DC AGENDA Wednesday, September 14 PHARMACOLOGY WORKSHOP 5:30 p.m. Registration and Light Refreshments 6:00 p.m. Welcome and Introductions 6:15 p.m. CVD Guideline-driven
Wednesday, October 24, 2018 Pre-Conference "Women's Health Summit: Cardiometabolic Health Across the Lifespan"
Wednesday, October 24, 2018 Pre-Conference "Women's Health Summit: Cardiometabolic Health Across the Lifespan" Start End Session Faculty 11:00 AM 11:10 AM Introduction to CMHC Women's Health Summit Pamela
Deep brain stimulation for movement disorders: state of the art and future perspectives
Zadar, Croatia, May 1 st - 3 rd, 2015 Deep brain stimulation for movement disorders: state of the art and future perspectives UNIVERSITY HOSPITAL DUBRAVA ZAGREB Unit of functional Neurosurgery Department
FINAL PROGRAM. The 36 th Meeting of the Scandinavian Sarcoma Group
FINAL PROGRAM The 36 th Meeting of the Scandinavian Sarcoma Group Helsinki Date: October 9-11, 2013 Place: Hotel Crowne Plaza Mannerheimentie 50 Helsinki 00260 Finland Hotel Front Desk +358-9-2521 0000
Smokefree Policies in Europe: Are we there yet?
Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially
9 TH NORDIC PSYCHIATRY ACADEMY
9 TH NORDIC 2011 PSYCHIATRY ACADEMY 9 TH NORDIC PSYCHIATRY ACADEMY COPENHAGEN, JANUARY 12 13TH, 2011 Adherence to Psychosis treatment Removing the Roadblocks With the support of: 9 TH NORDIC 2011 PSYCHIATRY
MEDICAL ONCOLOGY ESO-ESMO EASTERN EUROPE AND BALKAN REGION MASTERCLASS IN. 27 June - 2 July 2014 Brdo, Slovenia. Chairs: T. Cufer, SI R.
Flyer MMO_(4 Mar)_screen 04.04.2014 09:33 Pagina 3 MASTERCLASS ESO-ESMO EASTERN EUROPE AND BALKAN REGION MASTERCLASS IN MEDICAL ONCOLOGY 27 June - 2 July 2014 Brdo, Slovenia Chairs: R. Herrmann, CH This
PROGRAMME. 8th INTERNATIONAL CONFERENCE ON PAEDIATRIC CONTINUOUS RENAL REPLACEMENT THERAPY (pcrrt)
www.pcrrtconferences.com Abstract deadline: 15th April 2015 8th INTERNATIONAL CONFERENCE ON PAEDIATRIC CONTINUOUS RENAL REPLACEMENT THERAPY (pcrrt) 16th - 18th July 2015 Queen Elizabeth II Conference Centre,
5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition
5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition SIXTH DRAFT OF THE PROGRAM AUGUST 28, 2014 Wednesday, October 5, 2016 08:00-16:30 Post Graduate course (To be developed by the
INNOVATIVE PARTNERSHIP FOR ACTION AGAINST CANCER (ipaac) Official ipaac Joint Action presentation
INNOVATIVE PARTNERSHIP FOR ACTION AGAINST CANCER (ipaac) GENERAL INFORMATION The Innovative Partnership for Action Against Cancer (ipaac) Joint Action, which has been selected for funding under the Third
Master class in preventive cardiology Focus on diabetes and cardiovascular disease Geneva April
Master class in preventive cardiology Focus on diabetes and cardiovascular disease Geneva April 14 2011 Introduction Course objectives A review of available guidelines Lars Rydén Cardiology Unit Department
EFORT Barcelona 2018 Congress
EFORT Barcelona 2018 Congress General Assembly meeting Prof. Thierry Bégué Chair EFORT Science Committee 19 th EFORT Congress Barcelona 2018: Save the dates! Congress venue general information Barcelona
13 th Congress of the European Hip Society
13 th Congress of the European Hip Society Congress President: Dr. Berend Willem Schreurs, Nijmegen CALL FOR ABSTRACTS 20 22 September 2018 The Hague, The Netherlands www.ehs-congress.org 13 th Congress
PRE-CONFERENCE ACTIVITIES TUESDAY 4 TH - WEDNESDAY 5 TH SEPTEMBER 2018
PRE-CONFERENCE ACTIVITIES TUESDAY 4 TH - WEDNESDAY 5 TH SEPTEMBER 2018 TRANSPOSE MEETING PH.D. MASTER CLASSES 1 2 TRANSPOSE members are invited to attend the pre-conference TRANSPOSE meeting September
Treating the elderly patients with type 2 diabetes mellitus
Treating the elderly patients with type 2 diabetes mellitus Niki Katsiki MSc, PhD, MD, FRSPH IASO/EASO Scope Member EASD Diabetes & Cardiovascular Disease Group Member Member of the Executive Board of
Satellite Symposia Agenda
Satellite Symposia Agenda Lilly - The transition to injectable therapies: Navigating clinical and emotional challenges in T2DM 04/12/2017 12:30 14:30 Conference A 12:30 Welcome and introduction Chair Hassanein
The Many Faces of T2DM in Long-term Care Facilities
The Many Faces of T2DM in Long-term Care Facilities Question #1 Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment
Survey Responses to the EUROPEAN COCOA FORUM 2016
Survey Responses to the EUROPEAN COCOA FORUM The survey was sent to all delegates, speakers and moderators who took part in the European Cocoa Forum in Dubrovnik, and aimed at gathering feedback on the
Navigating the New Options for the Management of Type 2 Diabetes
Navigating the New Options for the Management of Type 2 Diabetes Clinical Associate Professor Mark Kennedy Department of General Practice, University of Melbourne Chair, Primary Care Diabetes Society of
Drug Treatment and HIV Prevention
Co-operation Group to Combat Drug Abuse and illicit trafficking in Drugs TRAINING WORKSHOP Drug Treatment and HIV Prevention Oblast Kiev, 5-7 November 2018 PROGRAMME Monday 5 November 2018 10:00 Arrival
FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?
FOURIER STUDY Did the study achieve its main objective? 2 15% 1 5% 9.8% YES FOURIER compared Repatha with placebo in patients who were taking a statin and had hardening or narrowing of the arteries and
HEART RHYTHM 2018 WORLD HEART RHYTHM CONFERENCE. Let s Explore the Rhythm of the Heart
15+ Interactive Sessions 10+ Keynote Lectures 40+ Scientific Sessions 3+ Workshops 30+ Posters HEART RHYTHM 2018 B2B Meetings WORLD HEART RHYTHM CONFERENCE November 15-17 Istanbul, Turkey Let s Explore
2018 Meeting of the. Working Group on Obesity, Diabetes and the High Risk Patient
ESH Organizer: Working Group on Obesity, Diabetes and the High Risk Patient EUROPEAN SOCIETY OF HYPERTENSION 2018 Meeting of the Working Group on Obesity, Diabetes and the High Risk Patient EUROPEAN SOCIETY
Gli inibitori di SGLT-2 possono essere impiegati nel diabete di tipo 1?
Impatto degli inibitori di SGLT-2 nei pazienti con diabete di tipo 2 Corso SID Hotel Michelangelo, Milano. 26 Giugno 2018 Gli inibitori di SGLT-2 possono essere impiegati nel diabete di tipo 1? Emanuele
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017 Mary L. Yost 404-520-6652 , LLC 23 Ridge Rd. Beaufort, SC 20097 Copyright Pending 2017 All rights reserved,
PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT
UNITED NATIONS A General Assembly Distr. LIMITED A/HRC/11/L.16 16 June 2009 Original: ENGLISH HUMAN RIGHTS COUNCIL Eleventh session Agenda item 3 PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL,
Nordic Shoulder and Elbow Conference
8th Triennial Nordic Shoulder and Elbow Conference 16-17 May 2019 International faculty COURSE CHAIRMAN: Ilkka Sinisaari VENUE: Clarion Hotel, Helsinki, Tyynenmerenkatu 2, Helsinki PROGRAMME NORDIC SHOULDER
European Association of Dental Public Health Prevention of Oral Cancer
European Association of Dental Public Health Prevention of Oral Cancer Special Interest Working Group Thursday 14th November 2013 PD Dr. Katrin Hertrampf, MPH Dr. Colwyn Jones, Associate Editor Malta 2013
Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6 10
6 Diabetes Care Volume 41, January 2018 PERSPECTIVES IN CARE Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6 10 https://doi.org/10.2337/dc17-1223
4-5 October 2007, Belgrade, Serbia Hotel Slavija A, B P R O G R A M. Postgraduate Course on Diabetology
4-5 October 2007, Belgrade, Serbia Hotel Slavija A, B P R O G R A M Postgraduate Course on Diabetology Screening and Prevention of Type 2 Diabetes Mellitus P r o g r a m M G S D Postgraduate Course on
Why is Earlier and More Aggressive Treatment of T2 Diabetes Better?
Blood glucose (mmol/l) Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Disclosures Dr Kennedy has provided CME, been on advisory boards or received travel or conference support from:
International CytoSorb Users Meeting. March 14 th Hotel Marivaux, Brussels
3 rd International CytoSorb Users Meeting March 14 th 2016 - Hotel Marivaux, Brussels 3 rd International CytoSorb Users Meeting Dear CytoSorb user, We are pleased to invite you to our 3rd International
23rd Congress of the European Association of Hospital Pharmacists
Tuesday, 20 March 12.00-17.00 Wednesday, 21 March 07.00-17.00 08.30-10.15 Opening ceremony & Keynote 1 - A global view of infectious diseases 10.15 Exhibition opens 10.15-11.45 Coffee break 10.30-11.45
DIOXIN SYMPOSIUM MEETING PLANNING
DIOXIN SYMPOSIUM MEETING PLANNING History & General Information A listing of future and past Dioxin Symposia can be found on the Symposium page. The International Dioxin Symposium has been held annually
The GUIDANCE study. Kamlesh Khunti University of Leicester, UK. on behalf of the GUIDANCE Study Group
The GUIDANCE study Guillaume Charpentier, Kris Doggen, Noëmi Debacker, Kees Gorter, Odile Juy Christiane Kellner, Kamlesh Khunti, Oliver Kuß, Ulf Lindblad, Arne Melander, Lena Minning, Ulrich Müller, John
Tobacco control measures in the Dutch National Prevention Agreement and expected tobacco industry responses
Tobacco control measures in the Dutch National Prevention Agreement and expected industry responses Gera Nagelhout & Barbara van Straaten, January 2019 Background The Dutch government has published a National
PROTEZIONE DAL DANNO RENALE NEL DIABETE TIPO 2: RUOLO DEI NUOVI FARMACI. Massimo Boemi UOC Malattie Metaboliche e Diabetologia IRCCS INRCA Ancona
PROTEZIONE DAL DANNO RENALE NEL DIABETE TIPO 2: RUOLO DEI NUOVI FARMACI Massimo Boemi UOC Malattie Metaboliche e Diabetologia IRCCS INRCA Ancona Disclosure Dr Massimo Boemi has been granted as speaker
Preventing Serious Health Consequences of Type 2 Diabetes
Preventing Serious Health Consequences of Type 2 Diabetes The Evidence Hertzel C. Gerstein MD MSc FRCPC Professor and Population Health Institute Chair in Diabetes Research McMaster University and Hamilton
Program Agenda. Ottawa Heart Research Conference (OHRC): Steadying the Future of Atrial Fibrillation. Thursday, June 2 nd (Day 1)
Ottawa Heart Research Conference (OHRC): Steadying the Future of Atrial Fibrillation Thursday, June 2 nd (Day 1) 8:00 am Welcome Message Drs. David Birnie, Peter Liu, and Thierry Mesana 8:15 9:35 am Session
SCIENTIFIC PROGRAMME 17 th CPD: Diabetes Asia 2018 Conference July 26-29, 2018
SCIENTIFIC PROGRAMME 17 th CPD: Diabetes Asia 2018 Conference July 26-29, 2018 120618 DAY 1 - JULY 26, 2018 (THURSDAY) 0700-0815 REGISTRATION 0815-0900 PLENARY 1 0900-0945 PLENARY 2 0945-1015 COFFEE BREAK
EFORT Expert Meet Expert Forum. Forum. Lower extremity fractures: Updates and problems. Case Discussions/Workshops
xxxxxxxxx ExMex xxxxxxxxxxxxx Forum Ljubljana, Slovenia 23-24 April 2015 Case Discussions/Workshops EFORT Expert Meet Expert Forum Ljubljana, Slovenia: 23-24 April 2015 Lower extremity fractures: Updates
ESPACOMP SCIENTIFIC MEETING PROGRAM
Version 29.06.2018 SDG 22th ESPACOMP conference - Dublin, Ireland (European Society for Patient Adherence, COMpliance and Persiste nce) THURSDAY, NOVEMBER 29TH TO SATURDAY, DECEMBER 1ST, 2018 ESPACOMP
LEBANON. WCPT COUNTRY PROFILE December 2018
LEBANON WCPT COUNTRY PROFILE December 2018 LEBANON NUMBERS 1600 1400 1200 1000 800 600 400 200 0 Physical therapists in the country Members in MO 1,480 1,480 Total PTs in country 800000 700000 600000 500000
Models of preventive care in clinical practice to achieve 25 by 25
Models of preventive care in clinical practice to achieve 25 by 25 Professor David A Wood Garfield Weston Professor of Cardiovascular Medicine International Centre for Circulatory Health Imperial College